Skip to main content

Table 5 Treatment, complications and outcomes of patients aged <65 years and ≥65 years with liver abscess

From: Clinical and epidemiological characteristics of pyogenic liver abscess in people 65 years or older versus people under 65: a retrospective study

 

Total

Aged <65 years

Aged ≥65 years

Odds ratio (CI 95%)

p-value

 

N

%

N

%

N

%

  

Treatment

 Antibiotic alone

31

31.6

11

27.5

20

34.5

1.4 (0.6, 3.3)

0.5

 Antibiotic + percutaneous aspiration

60

61.2

28

70

32

55.2

0.5 (0.2, 1.2)

0.1

 Antibiotic + surgical drainage ± percutaneous aspiration

7

7.1

1

2.5

6

10.3

4.5 (0.5, 38.9)

0.1

Antibiotics useda

 Penicillins/beta-lactamase inhibitors

31

31.6

16

40

15

25.9

0.5 (0.2, 1,2)

0.1

 Metronidazole

25

26.5

14

35.0

12

20.7

4.5 (0.2, 1.2)

0.1

 Carbapenems

23

23.5

9

22.5

14

24.1

1,1 (0.4, 2.8)

0.8

 Fluoroquinolones

20

20.4

7

17.5

13

22.4

1.4 (0.5, 3.8)

0.5

 Cephalosporins

15

25.5

8

20.0

17

29,3

1.7 (0.6, 4.3)

0.3

Complications

 Any complication

54

55.1

17

42.5

37

68.5

2.3 (1.04, 5.4)

0.04

 Severe complications

25

25.5

5

12.5

20

34.5

3.7 (1.2, 10.8)

0.01

Type of complications

 Septic shock

14

14.3

2

5.0

12

20.7

4.9 (1.04, 23)

0.03

 Pleural effusion

14

14.3

6

15.0

8

13.8

0.9 (0.3, 2.8)

0.9

 Acute renal failure

8

8.2

1

2.5

7

12.1

5.3 (0.6, 45.3)

0.09

 Cardiac complications

8

8.2

1

2.5

7

12.1

5.3 (0.6, 45)

0.09

 Thrombosis

6

6.1

4

10.0

2

2.0

0.3 (0.05, 1.8)

0.2

 Biliary-pancreatic complication

5

5.1

2

5.0

3

5.1

2.1 (0.5, 11)

0.8

 Infectious complications

4

4.1

1

2.5

3

5.2

2.1 (0.2, 21, 2)

0.5

 Peritonitis

1

1.0

0

0

1

1.7

NA

1

 Abdominal haematoma

1

1.0

0

0

1

1.7

NA

1

Outcome

 Death

8

8.2

0

0

8

13.8

NA

0.02

 

mean

SD

mean

SD

mean

SD

  

Admission days

19.3

12.8

19.5

11.9

18.9

13.5

NA

0.728

  1. CI confidence intervals, NA not applicable, SD standard deviation
  2. aOther antibiotics: amynoglucosides (n = 4), glycopetide (n = 3), clindamicin (n = 1)